| 產(chǎn)品名稱 | PHA 543613 dihydrochloride |
| 產(chǎn)品貨號 | Axon 2109 CAS [478148-58-2] MF C15H17N3O2.2HClMW 344.24 Purity: 99% Optical purity: Optically pure Soluble in water and DMSO Description Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia References Certificates Categories Extra info DG Wishka et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive (...). J. Med. Chem. 2006, 49(14), 4425-4436.? ? PR Krafft et al. PHA-543613 Preserves Blood–Brain Barrier Integrity After Intracerebral Hemorrhage in Mice. Stroke, 2013, 44(6), 1743-1747.? Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation nAChR Unclassified Pfizer Licensed Products nAChR agonist (α7 sub-unit selective) Chemical name (R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide dihydrochloride Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [478149-53-0] Order Size Unit Price Stock 10 mg €115.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
PHA 543613 dihydrochlorideAxon 2109 CAS [478148-58-2] MF C15H17N3O2.2HCl
Description
Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia
nAChR agonist (α7 sub-unit selective)
Chemical name(R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide dihydrochloride Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[478149-53-0] |
| 產(chǎn)品資料 |
